Skip to content
Technical University of Munich

Recent Publications

MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination

Activation of CD4 T cells determines the success of therapeutic hepatitis B vaccination in HBV-carrier mouse models

On the way to the clinics: the TherVacB vaccine

TherVacB—a therapeutic vaccine for the treatment of hepatitis B, developed at the Institute of Virology. Visit our website for more information

Current information on various viral diseases

SARS-CoV-2

Influenza

Measles

Norovirus

To top